Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size, Share, Trends and Forecast 2019

Description


The global Influenza A Virus, H3N2 Subtype Infections Drug market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Influenza A Virus, H3N2 Subtype Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza A Virus, H3N2 Subtype Infections Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
AbbVie Inc
AIMM Therapeutics B.V.
Aphios Corporation
Celltrion, Inc.
FluGen, Inc.
Glide Pharmaceutical Technologies Limited
ILiAD Biotechnologies, LLC
Inovio Pharmaceuticals, Inc.
Johnson & Johnson
Medicago Inc.
MedImmune, LLC
Mucosis B.V.
NanoViricides, Inc.
OPKO Health, Inc.
Sarepta Therapeutics, Inc.
VBI Vaccines Inc.
Visterra, Inc.
Zydus Cadila Healthcare Limited

Segment by Regions
North America
Europe
China
Japan

Segment by Type
NEO-8877
NP-025
NSC-61610
NVINF-1
Others

Segment by Application
Clinic
Hospital
Others

TABLE OF CONTENT

Table of Contents

Executive Summary
1 Influenza A Virus, H3N2 Subtype Infections Drug Market Overview
1.1 Product Overview and Scope of Influenza A Virus, H3N2 Subtype Infections Drug
1.2 Influenza A Virus, H3N2 Subtype Infections Drug Segment by Type
1.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Comparison by Type (2014-2025)
1.2.2 NEO-8877
1.2.3 NP-025
1.2.4 NSC-61610
1.2.5 NVINF-1
1.2.6 Others
1.3 Influenza A Virus, H3N2 Subtype Infections Drug Segment by Application
1.3.1 Influenza A Virus, H3N2 Subtype Infections Drug Consumption Comparison by Application (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Market by Region
1.3.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size
1.4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2014-2025)
1.4.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Production (2014-2025)

2 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Competition by Manufacturers
2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Manufacturers (2014-2019)
2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Share by Manufacturers (2014-2019)
2.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Influenza A Virus, H3N2 Subtype Infections Drug Production Sites, Area Served, Product Types
2.5 Influenza A Virus, H3N2 Subtype Infections Drug Market Competitive Situation and Trends
2.5.1 Influenza A Virus, H3N2 Subtype Infections Drug Market Concentration Rate
2.5.2 Influenza A Virus, H3N2 Subtype Infections Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Regions
3.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Regions
3.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Regions (2014-2019)
3.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Influenza A Virus, H3N2 Subtype Infections Drug Production
3.4.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
3.4.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production
3.5.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
3.5.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Influenza A Virus, H3N2 Subtype Infections Drug Production (2014-2019)
3.6.1 China Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
3.6.2 China Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production (2014-2019)
3.7.1 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate (2014-2019)
3.7.2 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption by Regions
4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption by Regions
4.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Consumption (2014-2019)
4.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug Consumption (2014-2019)
4.4 China Influenza A Virus, H3N2 Subtype Infections Drug Consumption (2014-2019)
4.5 Japan Influenza A Virus, H3N2 Subtype Infections Drug Consumption (2014-2019)

5 Global Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price Trend by Type
5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Market Share by Type (2014-2019)
5.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Type (2014-2019)
5.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2014-2019)
5.4 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Growth by Type (2014-2019)

6 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Analysis by Applications
6.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Market Share by Application (2014-2019)
6.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Influenza A Virus, H3N2 Subtype Infections Drug Business
7.1 AbbVie Inc
7.1.1 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.1.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.1.3 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 AIMM Therapeutics B.V.
7.2.1 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.2.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.2.3 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Aphios Corporation
7.3.1 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.3.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.3.3 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Celltrion, Inc.
7.4.1 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.4.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.4.3 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 FluGen, Inc.
7.5.1 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.5.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.5.3 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Glide Pharmaceutical Technologies Limited
7.6.1 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.6.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.6.3 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 ILiAD Biotechnologies, LLC
7.7.1 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.7.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.7.3 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Inovio Pharmaceuticals, Inc.
7.8.1 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.8.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.8.3 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.9.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.9.3 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Medicago Inc.
7.10.1 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production Sites and Area Served
7.10.2 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction, Application and Specification
7.10.3 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 MedImmune, LLC
7.12 Mucosis B.V.
7.13 NanoViricides, Inc.
7.14 OPKO Health, Inc.
7.15 Sarepta Therapeutics, Inc.
7.16 VBI Vaccines Inc.
7.17 Visterra, Inc.
7.18 Zydus Cadila Healthcare Limited

8 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Cost Analysis
8.1 Influenza A Virus, H3N2 Subtype Infections Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Influenza A Virus, H3N2 Subtype Infections Drug
8.4 Influenza A Virus, H3N2 Subtype Infections Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Influenza A Virus, H3N2 Subtype Infections Drug Distributors List
9.3 Influenza A Virus, H3N2 Subtype Infections Drug Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Forecast
11.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast
11.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Growth Rate Forecast (2019-2025)
11.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price and Trend Forecast (2019-2025)
11.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Forecast by Regions (2019-2025)
11.2.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast (2019-2025)
11.2.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast (2019-2025)
11.2.3 China Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast (2019-2025)
11.2.4 Japan Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue Forecast (2019-2025)
11.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast by Regions (2019-2025)
11.3.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast (2019-2025)
11.3.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast (2019-2025)
11.3.3 China Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast (2019-2025)
11.3.4 Japan Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast (2019-2025)
11.4 Global Influenza A Virus, H3N2 Subtype Infections Drug Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Influenza A Virus, H3N2 Subtype Infections Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

Choose License Type

Checkout Inquiry Sample